Ajayi AA, Sofowora GG, Ladipo GO. Explaining heart failure Hyper-mortality in sub saharan africa: global genomic and environmental contribution. J Natl Med Assoc. 2020;112(2):141–57.
Google Scholar
Gillum RF. The burden of cardiovascular disease in sub-Saharan Africa and the black diaspora. J Racial Ethn Health Disparities. 2018;5(6):1155–8.
Google Scholar
Alcaide-Aldeano A, Garay A, Alcoberro L, Jiménez-Marrero S, Yun S, Tajes M, et al. Iron deficiency: impact on functional capacity and quality of life in heart failure with preserved ejection fraction. J Clin Med. 2020;9(4):1199.
Google Scholar
Johansson I, Joseph P, Balasubramanian K, McMurray JJV, Lund LH, Ezekowitz JA, et al. Health-related quality of life and mortality in heart failure: the global congestive heart failure study of 23 000 patients from 40 countries. Circulation. 2021;143(22):2129–42.
Akintunde AA, Akinlade OM, Egbewale BE, Opadijo OG. Iron deficiency anaemia in Nigerians with heart failure (IDAN-HF): therapeutic efficacy of iron replacement: an interventional study. Niger J Clin Pract. 2021;24(1):21–7.
Google Scholar
Akintunde AA, Aworanti OW. Pattern of anaemia and its correlates in Nigerians with HF. Ann Ib Postgrad Med. 2020;18(1):51–9.
Google Scholar
Loncar G, Obradovic D, Thiele H, von Haehling S, Lainscak M. Iron deficiency in Heart Failure. ESC Heart Fail. 2021;8(4):2368–79.
Google Scholar
Dutt S, Hamza I, Bartnikas TB. Molecular mechanisms of iron and heme metabolism. Annu Rev Nutr. 2022;42:311–35.
Google Scholar
Paolillo S, Scardovi AB, Campodonico J. Role of comorbidities in heart failure prognosis part I: anaemia, iron deficiency, diabetes, atrial fibrillation. Eur J Prev Cardiol. 2020;27(2suppl):27–34.
Google Scholar
Martens P, Nijst P, Verbrugge FH, Smeets K, Dupont M, Mullens W. Impact of iron deficiency on exercise capacity and outcome in heart failure with reduced, mid-range and preserved ejection fraction. Acta Cardiol. 2018;73(2):115–23.
Google Scholar
Chopra VK, Anker SD, Anaemia. Iron deficiency and heart failure in 2020: facts and numbers. ESC Heart Fail. 2020;7(5):2007–11.
Google Scholar
Jacob C, Altevers J, Barck I, Hardt T, Braun S, Greiner W. Retrospective analysis into differences in heart failure patients with and without iron deficiency or anaemia. ESC Heart Fail. 2019;6(4):840–55.
Google Scholar
Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM, et al. Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial. JAMA. 2017;317:1958–66.
Google Scholar
Beale A, Carballo D, Stirnemann J, Garin N, Agoritsas T, Serratrice J, et al. Iron deficiency in acute decompensated HF. J Clin Med. 2019;8:1569.
Google Scholar
Beattie JM, Khatib R, Phillips CJ, Williams SG. Iron deficiency in 78,805 people admitted with HF across england: A retrospective cohort study. Open Heart. 2020;7:e001153.
Google Scholar
Núñez J, Monmeneu JV, Mollar A, Núñez E, Bodí V, Miñana G, et al. Left ventricular ejection fraction recovery in patients with HF treated with intravenous iron: A pilot study. ESC Heart Fail. 2016;3:293–8.
Google Scholar
Moliner PA, Jankowska E, Van Veldhuisen DJ, Farre N, Rozentryt P, Enjuanes C, et al. Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic HF. Int J Cardiol. 2017;243:360–6.
Google Scholar
McDonagh T, MacDougall IC. Iron therapy for the treatment of iron deficiency in chronic HF: intravenous or oral? Eur J Heart Fail. 2015;17:248–62.
Google Scholar
McDonagh T, Damy T, Doehner W, Lam CS, Sindone A, Van Der Meer P, et al. Screening, diagnosis and treatment of iron deficiency in chronic HF: putting the 2016 European society of cardiology HF guidelines into clinical practice. Eur J Heart Fail. 2018;20:1664–72.
Google Scholar
Enjuanes C, Bruguera J, Grau M, Cladellas M, Gonzalez G, Meroño O, et al. Iron status in chronic HF: impact on symptoms, functional class and submaximal exercise capacity. Rev Esp Cardiol. 2016;69:247–55.
Google Scholar
Comin-Colet J, Enjuanes C, Gonzalez G, Torrens A, Cladellas M, Meroño O, et al. Iron deficiency is a key determinant of health-related quality of life in patients with chronic HF regardless of anaemia status. Eur J Heart Fail. 2013;15:1164–72.
Google Scholar
Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M, Masuyama T. Adaptive response of the heart to long-term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol. 2009;296:H585-93.
Google Scholar
Keller-Ross ML, Larson M, Johnson BD. Skeletal muscle fatigability in HF. Front Physiol. 2019;21:10:129.
Google Scholar
Caminiti G, Sposato B, Volterrani M. The role of iron deficiency in HF. Eur Heart J Suppl. 2023;26(25Suppl C):C306-8.
Google Scholar
Houstis NE, Eisman AS, Pappagianopoulos PP, Wooster L, Bailey CS, Wagner PD, et al. Exercise intolerance in HF with preserved ejection fraction: diagnosing and ranking its causes using personalized O2 pathway analysis. Circulation. 2017;137:148–61.
Google Scholar
Wijk SS, Van Empel V, Davarzani N, Maeder MT, Handschin R, Pfisterer ME, et al. TIME-CHF Investigators. Circulating biomarkers of distinct pathophysiological pathways in HF with preserved vs. reduced left ventricular ejection fraction. Eur J Heart Fail. 2015;17:1006–14.
Paulus WJ, Tschöpe C. A novel paradigm for HF with preserved ejection fraction. J Am Coll Cardiol. 2013;62:263–71.
Google Scholar
Wijk SSV, Van Empel V, Davarzani N, Maeder MT, Handschin R, Pfisterer ME, ,;TIME-CHFInvestigators. Circulating biomarkers of distinct pathophysiological pathways in HF with preserved vs. reduced left ventricular ejection fraction. Eur J Heart Fail. 2015;17:1006–14.
Google Scholar
Hu D, Liu J, Zhang L, Bai X, Tian A, Huang X, et al. Health Status Predicts Short- and Long-Term Risk of Composite Clinical Outcomes in Acute HF. JACC Heart Fail. 2021;9(12):861–73.
Google Scholar
Jankowska EA, Ponikowski P. Iron deficiency in HF: A Korea-Oriented review. Int J Heart Fail. 2023;5(4):173–83.
Google Scholar
Rocha BML, Cunha GJL, Menezes Falcão LF. The burden of iron deficiency in HF: therapeutic approach. J Am Coll Cardiol. 2018;71(7):782–93.
Google Scholar
Anker SD, Khan MS, Butler J, von Haehling S, Jankowska EA, Ponikowski P, Friede T. Effect of intravenous iron replacement on recurrent HF hospitalizations and cardiovascular mortality in patients with HF and iron deficiency: A bayesian meta-analysis. Eur J Heart Fail. 2023;25(7):1080–90.
Google Scholar
Kalra PR, Cleland JGF, Petrie MC, Thomson EA, Kalra PA, Squire IB, IRONMAN Study Group, et al. Intravenous ferric derisomaltose in patients with HF and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet. 2022;400(10369):2199–209. https://doi.org/10.1016/S0140-6736(22)02083-9.
Google Scholar
Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. FAIR-HF trial investigators. Ferric carboxymaltose in patients with HF and iron deficiency. N Engl J Med. 2009;361:2436–88.
Google Scholar
Kosiborod MN, Jhund PS, Docherty KF, Diez M, Petrie MC, Verma S, et al. Effects of Dapagliflozin on symptoms, function, and quality of life in patients with HF and reduced ejection fraction: results from the DAPA-HF. Trial Circulation. 2020;141:90–9.
Google Scholar
Butler J, Anker SD, Filippatos G, Khan MS, Ferreira JP, Pocock SJ, et al. EMPEROR-reduced trial committees and investigators. Empagliflozin and health-related quality of life outcomes in patients with HF with reduced ejection fraction: the EMPEROR-Reduced trial. Eur Heart J. 2012;42:1203–12.
Google Scholar
Forman DE, Fleg JL, Kitzman DW, Brawner CA, Swank AM, McKelvie RS, et al. 6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic HF. J Am Coll Cardiol. 2012;60:2653–61.
Google Scholar
Shoemaker MJ, Curtis AB, Vangsnes E, Dickinson MG. Triangulating clinically meaningful change in the six-minute walk test in individuals with chronic HF: a systematic review. Cardiopulm Phys Ther J. 2012;23(3):5–15.
Google Scholar
Opasich C, Pinna GD, Mazza A, Febo O, Riccardi R, Riccardi PG, et al. Six-minute walking performance in patients with moderate-to-severe HF; is it a useful indicator in clinical practice? Eur Heart J. 2001;22(6):488–96.
Google Scholar